About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Philadelphia | 17,599 Studies Near You

Clinical TrialsPhiladelphia

Clinical Trials in Philadelphia

Discover 17,599 clinical trials near Philadelphia, Pennsylvania. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1001-1020 of 17,599 trials

TerminatedEfficacy of Dapsone as a Steroid Sparing Agent in Pemphigus VulgarisThe purpose of this 12-month study was to determine the efficacy of dapsone as a glucocorticoid-sparing agent in maintenance phase pemphigus vulgaris.NCT00429533·Chicago, Illinois and 7 others CompletedG551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2)The goal of this research study is to collect blood and urine samples from people who have either the R117H type of CF or the non-G551D gating type of CF to be kept for future…NCT01521338·Birmingham, Alabama and 35 others

Find Trials by Condition in Philadelphia

Breast Cancerin Philadelphia Lung Cancerin Philadelphia Prostate Cancerin Philadelphia Colorectal Cancerin Philadelphia Melanomain Philadelphia Leukemiain Philadelphia Lymphomain Philadelphia Pancreatic Cancerin Philadelphia Ovarian Cancerin Philadelphia Brain Cancerin Philadelphia

Data from ClinicalTrials.govTerms

TerminatedPhase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)This was a parallel treatment, Phase 2, randomized, double-blind study to assess the efficacy, safety, tolerability, PK, and PD of twice daily (BID) oral SAR443820 compared with…NCT05237284·La Jolla, California and 62 others

CompletedSensitive Periods in Early Flavor LearningFlavor is the primary dimension by which young children determine food acceptance.NCT00994747·Philadelphia, Pennsylvania

CompletedStudy to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in Human Immunodeficiency Virus (HIV-1) Infected, Antiretroviral Treatment-Naive AdultsThis primary objective of this study is to evaluate the efficacy of a fixed dose combination (FDC) containing bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) versus…NCT02607956·Phoenix, Arizona and 124 others

CompletedPost-Traumatic Stress Symptoms (PTSS) in Transplant RecipientsThis study is conducted to better understand Post-Traumatic Stress Symptoms (PTSS) in adolescent transplant recipients and their parent/guardian and to see if PTSS play a role in…NCT02892266·Los Angeles, California and 12 others

RecruitingA Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyThe purpose of this study is to compare how long the participants are disease-free (progression-free survival) and and the length of time until a participant dies (overall…NCT06750094·Chandler, Arizona and 250 others

CompletedC-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate CancerPatients with castrate resistant prostate cancer (CRPCA) with osseous metastatic disease planning to undergo Ra-223 therapy may be eligible for this study.NCT02715583·Philadelphia, Pennsylvania

CompletedXofluza-Wearables Feasibility-StudyThe goal of this prospective, interventional, single-center study is to assess whether the early detection of Influenza with smart wearable device algorithms and alerting, rapid…NCT06161454·Philadelphia, Pennsylvania

CompletedStudy to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid DependenceThe purpose of the study was to assess the efficacy of induction treatment with buprenorphine/naloxone (BNX) sublingual tablet s compared with induction treatment with…NCT01848054·Birmingham, Alabama and 13 others

CompletedInvestigating Age-Related Macular DegenerationAge-related macular degeneration (ARMD) affects older Americans and can lead to irreversible blindness.NCT00342251·Philadelphia, Pennsylvania

CompletedPhase 1 Study of EZN-2968 Weekly in Adult Patients With Advanced Solid Tumors or LymphomaThis is a Phase 1, open-label, non-randomized, dose-escalation study to determine the maximum tolerated dose (MTD), safety, tolerance, and pharmacologic profile of EZN-2968, a…NCT00466583·Durham, North Carolina and 2 others

UnknownProbiotics Pilot ProjectThis pilot study is designed to determine if ingestion of Bacillus probiotics can cause alteration in levels of S. aureus colonization in the nose and intestine in preoperative…NCT04247854·Philadelphia, Pennsylvania

Active not recruitingA Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).The purpose of this study is to evaluate the efficacy, safety and pharmacokinetics of aficamten in a pediatric population with symptomatic obstructive hypertrophic cardiomyopathy…NCT06412666·Phoenix, Arizona and 35 others

TerminatedAn Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEETo assess the long-term safety and tolerability of XEN496 in pediatric subjects with KCNQ2 developmental and epileptic encephalopathy (KCNQ2-DEE) who had participated in the…NCT04912856·Philadelphia, Pennsylvania and 3 others

Enrolling by invitationPhase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)This is a long- term extension of the double-blind trials APPROACH (CYB003-002) and EMBRACE (CYB003-003).NCT06605105·Phoenix, Arizona and 48 others

TerminatedInterStim Micro Post Market Clinical Follow-up Study (ELITE)Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the InterStim Micro System for sacral neuromodulation.NCT04506866·Jacksonville, Florida and 23 others

CompletedFundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's DiseaseTo determine the effect of a novel gut microbiota-targeted therapeutic regimen (bowel lavage and antibiotics with or without an antifungal) in the management of active Crohn's…NCT02765256·Philadelphia, Pennsylvania

CompletedPhase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CFThe primary objective of this study is to evaluate the safety and efficacy of a CAT regimen with aztreonam for inhalation solution (AZLI) and tobramycin inhalation solution (TIS)…NCT01641822·Birmingham, Alabama and 70 others

TerminatedNivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung CancerThis phase II trial studies how well Nivolumab, Cisplatin, and Pemetrexed Disodium or Gemcitabine Hydrochloride in treating patients with stage I-IIIA non-small cell lung cancer…NCT03366766·Abington, Pennsylvania and 1 other

PreviousPage 51 of 880Next

Diabetes

in Philadelphia

Heart Diseasein Philadelphia